Radiation Oncology/RTOG Trials/0319

From Wikibooks, open books for an open world
< Radiation Oncology‎ | RTOG Trials
Jump to: navigation, search


RTOG 03-19 (Breast)

  • Title: A Phase I/II Trial to Evaluate 3D-CRT Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma
  • Objective:
  • Protocol:
    • 38.5 Gy Total/10 fractions (3.85 Gy per fraction), 2 fractions/day (separated by 6 hours), Given in 5 consecutive working days
    • Radiotherapy should begin within eight weeks of surgery (If chemotherapy is given first, RT begins 2 weeks after the last cycle of chemotherapy)
  • Eligibility:
    • Invasive pathology; AJCC Stage I-II; single focus
    • Negative surgical margin; up to 3 LN+
  • Enrollment Target: 46 patients
  • Activation: August 15, 2003
  • Closed: April 30, 2004